July 31, 2020
Now available AVSOLA™
AVSOLA™ is a tumor necrosis factor (TNF) blocker indicated for: Crohn’s
Disease; Pediatric Crohn’s Disease; Ulcerative Colitis; Pediatric Ulcerative
Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis; and
Plaque Psoriasis.
Please see the full prescribing information.
Please see the full prescribing information.